Acuitas is a biotechnology company that works with partners and customers to develop new or improved medicines based on our internationally recognized capabilities in nanotechnology-based pharmaceutical product development. Acuitas provides delivery solutions for molecular therapeutics using lipid nanoparticles and specializes in messenger RNA (mRNA) delivery.

Acuitas Therapeutics is a private company incorporated in British Columbia, Canada. We were founded in February 2009 and are partnered with several biotechnology and pharmaceutical companies developing nucleic acid therapeutics.